Table 3.
Groups | anti-dsDNA autoantibody (IU/mL) | CH50 (U/L) | IgE (ng/mL) |
---|---|---|---|
MRL/lpr | 1216.610 ± 584.472 | 13.406 ± 3.776 | 39.269 ± 18.005 |
HCQ | 484.913 ± 115.394∗∗ | 16.700 ± 4.582∗∗ | 33.284 ± 16.444 |
LCP | 719.336 ± 229.275∗∗ | 17.484 ± 3.965∗∗ | 37.815 ± 10.451 |
LCF Low | 809.469 ± 211.999∗ | 17.212 ± 4.339∗∗ | 35.518 ± 17.325 |
LCF Medium | 879.090 ± 366.697∗ | 17.040 ± 4.107∗∗ | 34.761 ± 17.893 |
LCF High | 696.713 ± 127.242∗∗ | 16.971 ± 3.905∗∗ | 32.982 ± 15.000 |
MRL/lpr: lupus model group; HCQ: hydroxychloroquine sulfate tablet group; LCP: Langchuang Pill group; LCF Low: low dose of LCF granule group (0.97 g/kg/d); LCF Medium: medium dose of LCF granule group (1.95 g/kg/d); LCF High: high dose of LCF granule group (3.90 g/kg/d). Data are expressed as means ± SDs, n = 10. ∗ P < 0.05, ∗∗ P < 0.01 versus MRL/lpr.